Director dealing | 03-Apr-2024 | 14:00 | RNS |
Result of PrimaryBid Offer | 28-Mar-2024 | 16:23 | RNS |
Holding(s) in Company | 28-Mar-2024 | 14:18 | RNS |
Replacement - Subscription and Notice of GM | 25-Mar-2024 | 15:02 | RNS |
PrimaryBid Offer | 22-Mar-2024 | 07:01 | RNS |
Subscription, PrimaryBid Offer and Notice of GM | 22-Mar-2024 | 07:00 | RNS |
Extension to Convertible Loan Agreements | 14-Mar-2024 | 07:00 | RNS |
US Environmental Protection Agency positive report | 13-Mar-2024 | 07:00 | RNS |
EU Judgment – Company Response | 09-Feb-2024 | 07:59 | RNS |
EU Court Judgement | 31-Jan-2024 | 09:48 | RNS |
Trading Update and EU Case | 18-Jan-2024 | 07:00 | RNS |
Grant of options and PDMR dealing | 08-Jan-2024 | 07:00 | RNS |
Director appointment & grant of options | 02-Jan-2024 | 07:00 | RNS |
Options amendments | 28-Dec-2023 | 07:00 | RNS |
£1.0m convertible loan agreement | 18-Oct-2023 | 14:10 | RNS |
Currency | UK Pounds |
Share Price | 3.08p |
Change Today | -0.17p |
% Change | -5.23 % |
52 Week High | 9.25 |
52 Week Low | 2.10 |
Volume | 0 |
Shares Issued | 204.34m |
Market Cap | £6.29m |
RiskGrade | 282 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
0 @ 0.000p |
CFO | Ian Bristow |
CEO | Michael Laurier |
You are here: research